Correlation Between IPath Series and Innovator MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IPath Series and Innovator MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IPath Series and Innovator MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iPath Series B and Innovator MSCI Emerging, you can compare the effects of market volatilities on IPath Series and Innovator MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IPath Series with a short position of Innovator MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of IPath Series and Innovator MSCI.

Diversification Opportunities for IPath Series and Innovator MSCI

-0.88
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between IPath and Innovator is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding iPath Series B and Innovator MSCI Emerging in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator MSCI Emerging and IPath Series is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iPath Series B are associated (or correlated) with Innovator MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator MSCI Emerging has no effect on the direction of IPath Series i.e., IPath Series and Innovator MSCI go up and down completely randomly.

Pair Corralation between IPath Series and Innovator MSCI

Considering the 90-day investment horizon iPath Series B is expected to generate 7.66 times more return on investment than Innovator MSCI. However, IPath Series is 7.66 times more volatile than Innovator MSCI Emerging. It trades about 0.06 of its potential returns per unit of risk. Innovator MSCI Emerging is currently generating about 0.03 per unit of risk. If you would invest  4,810  in iPath Series B on March 21, 2025 and sell it today you would earn a total of  612.00  from holding iPath Series B or generate 12.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

iPath Series B  vs.  Innovator MSCI Emerging

 Performance 
       Timeline  
iPath Series B 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iPath Series B are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, IPath Series showed solid returns over the last few months and may actually be approaching a breakup point.
Innovator MSCI Emerging 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator MSCI Emerging are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Innovator MSCI is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

IPath Series and Innovator MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IPath Series and Innovator MSCI

The main advantage of trading using opposite IPath Series and Innovator MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IPath Series position performs unexpectedly, Innovator MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator MSCI will offset losses from the drop in Innovator MSCI's long position.
The idea behind iPath Series B and Innovator MSCI Emerging pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges